Literature DB >> 18415418

[Duration of the exteroceptive suppression of temporal muscle activity as a parameter for therapy control in tension-type headache-a pilot study.].

J Liepert1, M Tegenthoff, A Willweber-Strumpf.   

Abstract

UNLABELLED: The period of late exteroceptive suppression (ES 2) of the temporalis muscle is often shortened in patients with chronic tension-type headache. The present study was conducted to find out whether the ES 2 is influenced by muscle relaxation training and whether it is rather a state or a trait marker.
METHODS: The ES 2 was measured in seven female outpatients with chronic tension-type headache before, during, and after a 6-week period of muscle relaxation training. Single electrical stimuli were applied periorally during maximum teeth clenching, while the activity of temporalis muscle was recorded with surface EMG electrodes.
RESULTS: Before treatment, duration of the ES 2 was significantly shorter in patients than in a control group. Immediately after the 6-week period the ES 2 was normalized and no longer different from that in the controls. Another 16 weeks later the duration of ES 2 was reduced again, but had not returned to pretreatment values. The ES 2 data correlated slightly better with the patients' feeling of being relaxed than with reduction of headache.
CONCLUSIONS: The duration of ES 2 was modified by a muscle relaxation training in patients with chronic tension-type headache. Therefore, ES 2 is a state marker and is probably influenced by limbic structures. Measurement of ES 2 may not be only a diagnostic tool, but could also be useful in monitoring results of therapy in patients with tension-type headache.

Entities:  

Year:  1993        PMID: 18415418     DOI: 10.1007/BF02527637

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  10 in total

1.  An anatomical analysis of cortico-bulbar connexions to the pons and lower brain stem in the cat.

Authors:  H G KUYPERS
Journal:  J Anat       Date:  1958-04       Impact factor: 2.610

2.  [EMG analysis of exteroceptive suppression of temporal muscle activity in tension headache].

Authors:  T M Wallasch; M Reinecke; H D Langohr
Journal:  Nervenarzt       Date:  1991-02       Impact factor: 1.214

3.  Exteroceptive suppression and motor control of the masseter and temporalis muscles in normal man.

Authors:  E Godaux; J E Desmedt
Journal:  Brain Res       Date:  1975-03-07       Impact factor: 3.252

4.  Multiple clinical and paraclinical analyses of chronic tension-type headache associated or unassociated with disorder of pericranial muscles.

Authors:  J Schoenen; P Gerard; V De Pasqua; J Sianard-Gainko
Journal:  Cephalalgia       Date:  1991-07       Impact factor: 6.292

5.  Cutaneous silent period in masseter muscles: a clinical and electrodiagnostic evaluation.

Authors:  B W Ongerboer de Visser; C Goor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-07       Impact factor: 10.154

6.  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

Authors: 
Journal:  Cephalalgia       Date:  1988       Impact factor: 6.292

7.  Origin and central pathways of crossed inhibitory effects of afferents from the masseteric muscle on the masseteric motoneuron of the cat.

Authors:  Y Nakamura; S Mori; H Nagashima
Journal:  Brain Res       Date:  1973-07-16       Impact factor: 3.252

8.  Exteroceptive suppression of temporalis muscle activity in chronic headache.

Authors:  J Schoenen; B Jamart; P Gerard; P Lenarduzzi; P J Delwaide
Journal:  Neurology       Date:  1987-12       Impact factor: 9.910

9.  Exteroceptive silent period of temporalis muscle in menstrual headaches.

Authors:  J Schoenen; D Bottin; J Sulon; U Gaspard; R Lambotte
Journal:  Cephalalgia       Date:  1991-05       Impact factor: 6.292

10.  EMG analysis of the late exteroceptive suppression period of temporal muscle activity in episodic and chronic tension-type headaches.

Authors:  T M Wallasch; M Reinecke; H D Langohr
Journal:  Cephalalgia       Date:  1991-05       Impact factor: 6.292

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.